Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib study

Authors

Lyudmila Bazhenova
Dong-Wan Kim
Byoung Chul Cho
Sanjay Goel
Rebecca Heist
Theresa L Werner
Keith D Eaton
Judy S Wang
Shubham Pant
Douglas R Adkins
Collin M Blakely
Xiaohong Yan
Saskia Neuteboom
James G Christensen
Richard Chao
Todd Bauer

Publication Date

12-1-2024

Journal

Future Oncology

DOI

10.1080/14796694.2024.2418285

PMID

39513224

PMCID

PMC11654803

PubMedCentral® Posted Date

11-8-2024

PubMedCentral® Full Text Version

Post-print

Keywords

Humans, Male, Female, Middle Aged, Neoplasms, Aged, Adult, Aged, 80 and over, Mutation, Young Adult, Treatment Outcome

Published Open-Access

yes

Recommended Citation

Bazhenova, Lyudmila; Kim, Dong-Wan; Cho, Byoung Chul; et al., "Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib study" (2024). Faculty, Staff and Student Publications. 4051.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/4051